Trial Profile
An observational study of Dolutegravir-containing combination antiretroviral therapy (cART) assessing effectiveness in HIV-1 infected patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 02 Mar 2016 New trial record